When miR-193b-3p levels were increased, triosephosphate isomerase (TPI1) levels were decreased in both the plasma of T2DM patients and HepG2 hepatocellular carcinoma cells [224]. The gene discussed is TPI1; the disease is hepatocellular carcinoma.